These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6158585)

  • 1. Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy.
    Mahan DE; Bruce AW; Manley PN; Franchi L
    J Urol; 1980 Oct; 124(4):488-91. PubMed ID: 6158585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical demonstration of prostatic acid phosphatase: different secretion kinetics between normal, hyperplastic and neoplastic prostates.
    Mori K; Wakasugi C
    J Urol; 1985 May; 133(5):877-83. PubMed ID: 2580998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
    J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of acid phosphatase in the human prostate: normal and pathologic. Cytochemistry and biochemistry of acid phosphatases II.
    Aumüller G; Pohl C; van Etten RL; Seitz J
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 35(3):249-62. PubMed ID: 6169193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
    Truong T; Carmel M; Elhilali M; Cloutier D; Lehoux JG
    Prostate; 1985; 7(2):143-9. PubMed ID: 2413430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS; Cohen C; Demers LM; Budgeon LR
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue.
    Jöbsis AC; De Vries GP; Anholt RR; Sanders GT
    Cancer; 1978 May; 41(5):1788-93. PubMed ID: 348296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
    Fischer DR; Gevers W; Klerk JN; Kühn S
    Int Urol Nephrol; 1979; 11(2):111-8. PubMed ID: 89105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochemistry and biochemistry of acid phosphatases. VI: Immunoelectron microscopic studies on human prostatic and leukocytic acid phosphatases.
    Aumüller G; Seitz J
    Prostate; 1985; 7(2):161-9. PubMed ID: 2413431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
    Lee C; Murphy GP; Chu TM
    Cancer Res; 1980 Apr; 40(4):1245-8. PubMed ID: 7357554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the Gleason grading system.
    Sinha AA; Gleason DF; Wilson MJ; Wick MR; Reddy PK; Blackard CE
    Prostate; 1988; 13(1):1-15. PubMed ID: 2458582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of prostatic acid phosphatase.
    Yam LT; Janckila AJ; Lam WK; Li CY
    Prostate; 1981; 2(1):97-107. PubMed ID: 7024961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
    Bates RJ; Chapman CM; Prout GR; Lin CW
    J Urol; 1982 Mar; 127(3):574-80. PubMed ID: 6174741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Int; 1991; 46(1):6-8. PubMed ID: 1708923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme markers in human prostatic carcinoma.
    Chu TM; Wang MC; Kuciel R; Valenzuela L; Murphy GP
    Cancer Treat Rep; 1977; 61(2):193-200. PubMed ID: 68822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry.
    Jöbsis AC; De Vries GP; Meijer AE; Ploem JS
    Histochem J; 1981 Nov; 13(6):961-73. PubMed ID: 6175605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.